Eli Lilly is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...

Lilly is expected to post earnings of $5.54 per share for the current quarter, representing a year-over-year change of +41.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.8%.

Eli Lilly is the most likely healthcare stock to reach a $1 trillion valuation, and I believe it could hit that plateau by 2027. Eli Lilly's stock has surged close to 400% in five years.

Lilly's forward price-to-earnings (P/E) ratio currently tops 35, which is more than twice the average of 15.8 for the healthcare industry. 3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow ...

The latest trading day saw Eli Lilly (LLY) settling at $770.64, representing a +1.04% change from its previous close. ... The company's earnings report is set to go public on August 7, 2025.